by Genna Contino | Dec 5, 2024
As pharmaceutical giant Eli Lilly evolves its popular obesity and diabetes drug, the company has discovered positive side effects that could develop into spin-off medications. Users of GLP-1 drugs, which regulate blood sugar, appetite and digestion, have reported...
